Antagonizing the cannabinoid receptor type 1: a dual way to fight obesity.

D. Cota, S. Genghini, R. Pasquali, U. Pagotto
J Endocrinol Invest. 2003-10-01; 26(10): 1041-1044
DOI: 10.1007/bf03348205

PubMed
Lire sur PubMed



1. J Endocrinol Invest. 2003 Oct;26(10):1041-4.

Antagonizing the cannabinoid receptor type 1: a dual way to fight obesity.

Cota D(1), Genghini S, Pasquali R, Pagotto U.

Author information:
(1)Neuroendocrinology Group, Max-Planck-Institute of Psychiatry, Munich, Germany.

DOI: 10.1007/BF03348205
PMID: 14759080 [Indexed for MEDLINE]


Auteurs Bordeaux Neurocampus